web analytics
August 22, 2014 / 26 Av, 5774
Israel at War: Operation Protective Edge
 
 
At a Glance

Posts Tagged ‘drugs’

Israel Police Report 9% Rise in Calls for Help

Wednesday, May 14th, 2014

It’s going to be another long, hot summer for security personnel if the latest statistics are accurate.

Israel Police report they received more than nine million ‘100′ calls (Israel’s ‘911′) from Tel Aviv in 2013 — a nine percent rise over the previous year.

Annual police data showed the heaviest rate of calls came in the summer months, in June, July and August.

Of the 9,208,890 calls received by the national Israel Police dispatcher, 40,868 took place at one o’clock in the morning, an hour when many bars close. Only 3,731 crimes were reported between 5 am and 6 am – in that grey hour before dawn.

In 2012, 359,503 complaints went on to be processed by police and nearly one third of those — 89,580 — were for disturbing the peace.

Figures show that 40 percent of the calls originated from the southern and central regional districts. But 18 percent came solely from the city of Tel Aviv; not far behind, 14 percent originated in Jerusalem.

Car theft accounted for 55 percent of nearly 20,000 calls to police.

In addition, police reported that some 2,553 kilograms of hashish were seized during the year as well as 1,171 kilos of marijuana and 47,316 tablets of methamphetamine.

In 2012, there were 19, 352 arrests for drug use, 4,448 arrests for drug trafficking and 2,972 arrests for possession of drugs “not for personal use.”

Teva Wins FDA Approval for Leukemia Drug

Thursday, February 13th, 2014

The U.S. Food and Drug Administration (FDA) has granted Israeli-based Teva Pharmaceuticals full approval for Synribo, a drug that is injected for adults with a with chronic phase or accelerated phase of myeloid leukemia.

Chronic myeloid leukemia, also known as chronic myelogenous leukemia, is one of four main types of leukemia and is a cancer of the blood and bone marrow.

The FDA had given initial approval for the drug in October 2012 but said Teva had to provide additional clinical trial data before it could bring the drug to market.

“With this approval, based on the final analysis of two Phase II trials that evaluated efficacy and tolerability data of Synribo, we believe healthcare providers can be even more confident in the clinical profile of this important medicine, said Teva president and CEO global specialty medicines Rob Koremans.

Israeli Police Expose Palestinian Authority Drug Lab

Monday, December 23rd, 2013

Israeli police exposed a drug lab in the Palestinian Authority city of Tulkarm, located on the western edge of Samaria and less than 15 miles from Netanya. A police spokesperson explained that Tulkarm was chosen as a site for the drug lab because it is not easily accessible to the Israeli Police

A large force of police and IDF soldiers surrounded and then entered a house, where they discovered a large marijuana factory and more than 120 plants. The drugs were to be distributed in the coastal Sharon area,. Over 120 plants were found. The lab was run by Arab residents of Taybe, located in the Arab-dominated area between Netanya, Umm el-Fahm east of Hadera and Kfar Saba.

The lab was exposed after the police had over the past several months arrested several drug dealers involved in the distribution of drugs which originated in this lab.

Police Nab Sabbath Observant Drug Traffickers

Thursday, September 12th, 2013

Criminals who observe the Sabbath forgot that Torah also commands not to endanger others, but New York City narcotic agents have now made sure they can’t do so after arresting them on charges of multiple crimes, from illegal possession of narcotics to illegal possession of a weapon, according to CBS news.

The drug ring was comprised of five Brooklyn men who operated out of Sheepshead Bay, Brooklyn.

Police reportedly seized around 900 doses of heroin, as well 335 oxycodone pills, cocaine, Xanax, Suboxone and Klonopin from the group during their initial arrest in April. They also found a sawed-off shotgun and ammunition.

The name of the NYPD sting operation that led to the drug bust? Only After Sundown.

Though cavalier about New York’s drug laws, the group was scrupulous about observing the Sabbath. Text messages from members of the gang show them alerting their clientele of their weekly sundown-to-sunset hiatus.

“We are closing 7:30 on the dot and we will reopen Saturday 8:15 so if u need anything you have 45 mins to get what you want,” they wrote in a group text-message to clients.

Heroin-Addicted Would-Be Terrorist Not a Nazi

Thursday, August 1st, 2013

By Talia Lavin

New York loves nothing so much as a good scandal. So considering the carnival of a mayoral race that is now unfolding, it’s probably understandable some people might have missed this one: Aaron Greene, 31, a son of New York Jewish privilege, was sentenced today to seven years in prison for possession of explosives.

Greene was arrested in December after police found a cache of shotguns, bomb-making literature and several grams of a potent explosive known as HMTD in the Greenwich Village apartment he shared with his girlfriend, Morgan Gliedman, 27. Police say Greene planned to blow up the arch in Washington Square Park.

The story is a tabloid writer’s fantasy. Greene and Gliedman, who was nine months pregnant at the time of her arrest, are both heroin addicts. They are also both children of the New York Jewish elite. Gliedman is the scion of a wealthy Jewish family who attended Dalton, NYU and the Art Institute of Chicago. Greene’s father is a respected architect who helped design the Eldridge Street Synagogue. In the papers, Greene and Gliedman come off as rich-kid junkies with a fetish for weapons: Sid and Nancy meet the Weathermen, only a few decades late on both counts.

You’d think that would be enough for the tabloids. But the story of two nihilistic junkies about to give birth in an apartment full of sawed-off shotguns and a copy of “The Terrorist’s Encyclopedia” apparently wasn’t enough. Greene was reported to have attended Harvard, and to self-identify as a Nazi – the former claim refuted by the university, the latter by his attorney. The New York Post interpreted a lightning-bolt doodle that Greene used as a signature as the infamous symbol of the SS, and cited an anonymous source that declared Greene had a Nazi grandfather.

In reality, Greene’s relatives were survivors. In what may be the first instance of the Holocaust being used to defend a heroin-addicted terrorist, Greene’s lawyers gave this statement to the New York Times: “To state that the young man is a neo-Nazi when this is a man who comes from a family devastated by the Holocaust, based upon a mere doodle, is more than unfair, it is unforgivable.”

It’s almost August, so perhaps the Post and its brethren can be forgiven for getting a little hot under the collar. But fear not, New York: your trust-funded, drug-addled pregnant hippie terrorists are only that — not neo-Nazis or Harvard graduates.

Now isn’t there something about sexting we can read about?

Israel Rabbi Says Marijuana ‘Kosher’ if Medicinal

Sunday, June 30th, 2013

An Israeli Orthodox rabbi ruled that distributing and smoking medicinal marijuana is kosher, but using weed for fun is forbidden.

Ephraim Zalmanovich, the rabbi of Mazkeret Batia, a town south of Tel Aviv, made the distinction in a recent halachic ruling, NRG, the news site of the Maariv daily reported on Friday. Leading rabbis frequently weigh in on matters of reconciling halacha, or Jewish law, with modern living.

Rabbi Zalmanovich’s ruling modifies an opinion by Rabbi Chaggai Bar Giora, who in March told Israel’s Magazin Canabis, “If you smoke it, there is no problem whatsoever.”

Rabbi Zalmanovich, the author of a book on alcoholism in Judaism, said, “Taking drugs to escape this world in any excessive way is certainly forbidden.”

However, if the drug is administered to relieve pain, then the person giving it is “performing a mitzvah,” and the person using the drug is using it “in a kosher fashion.”

Approximately 11,000 Israelis use medicinal marijuana, including people with post-traumatic disorders and Parkinson’s disease, according to the Israeli health ministry.

Tel Aviv U Researcher Says Marijuana Can Halt Brain Damage

Friday, May 31st, 2013

Extremely low doses of marijuana’s psychoactive component can protect the brain before and after injury, according to Tel Aviv University Prof. Yosef Sarne.

Medical cannabis is often used by sufferers of chronic ailments, including cancer and post-traumatic stress disorder, to combat pain, insomnia, lack of appetite, and other symptoms but has not been  identified as being able to prevent damage to the body.

Prof. Sarne of the Adelson Center for the Biology of Addictive Diseases says that the drug has neuroprotective qualities and that extremely low doses of THC –  the psychoactive component of marijuana – protects the brain from long-term cognitive damage in the wake of injury from lack of oxygen, seizures, or toxic drugs. Brain damage can have consequences ranging from mild cognitive deficits to severe neurological damage.

Previous studies focused on injecting high doses of THC within a very short time frame of approximately 30 minutes  before or after injury. Prof. Sarne’s current research, published in the journals Behavioural Brain Research and Experimental Brain Research, demonstrates that even extremely low doses of THC around 1,000 to 10,000 times less than that in a conventional marijuana cigarette and administered over a wide window of up to seven days before or one to three days after injury can jumpstart biochemical processes which protect brain cells and preserve cognitive function over time.

This treatment, especially in light of the long time frame for administration and the low dosage, could be applicable to many cases of brain injury and be safer over time, Prof. Sarne says.

In the lab, the researchers injected mice with a single low dose of THC either before or after exposing them to brain trauma. A control group of mice sustained brain injury but did not receive the THC treatment. When the mice were examined three to seven weeks after initial injury, recipients of the THC treatment performed better in behavioral tests measuring learning and memory. Additionally, biochemical studies showed heightened amounts of neuroprotective chemicals in the treatment group compared to the control group.

The use of THC can prevent long-term cognitive damage that results from brain injury, the researchers conclude. One explanation for this effect is pre- and post-conditioning, whereby the drug causes minute damage to the brain to build resistance and trigger protective measures in the face of much more severe injury, explains Prof. Sarne. The low dosage of THC is crucial to initiating this process without causing too much initial damage.

According to Prof. Sarne, there are several practical benefits to this treatment plan.

Due to the long therapeutic time window, this treatment can be used not only to treat injury after the fact, but also to prevent injury that might occur in the future.

For example, cardiopulmonary heart-lung machines used in open heart surgery carry the risk of interrupting the blood supply to the brain, and the drug can be delivered beforehand as a preventive measure. In addition, the low dosage makes it safe for regular use in patients at constant risk of brain injury, such as epileptics or people at a high risk of heart attack.

Prof. Sarne is now working in collaboration with Prof. Edith Hochhauser of the Rabin Medical Center to test the ability of low doses of THC to prevent damage to the heart.

Preliminary results indicate that they will find the same protective phenomenon in relation to cardiac ischemia, in which the heart muscle receives insufficient blood flow.

Printed from: http://www.jewishpress.com/news/israel/tel-aviv-u-researcher-says-marijuana-can-halt-brain-damage/2013/05/31/

Scan this QR code to visit this page online: